Medpace Holdings (MEDP) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $4.25
- EPS estimate
- $3.98
- EPS surprise
- +6.83%
- Revenue surprise
- +2.58%
- Revenue
- $707.3M
- Revenue estimate
- $689.5M
- Reported
- Jul 22, 2026
Medpace reported Q2 2026 results on July 22, 2026. Earnings per share were $4.25, ahead of the $3.98 estimate by 6.83%. Revenue was $707.3 million against a $689.5 million consensus, a 2.58% beat. Compared with Q2 2025, EPS rose about 37% from $3.10 and revenue rose about 17% from $603.3 million. Revenue has now held near $707 million to $709 million for three quarters.
The longer record shows strong growth. Annual EPS rose from $7.32 in 2022 to $8.88 in 2023, $12.63 in 2024 and $15.30 in 2025. Annual revenue grew about 73% over the same span, from $1.46 billion to $2.53 billion. The first half of 2026 adds up to $8.53 per share, about 26% more than the $6.77 of a year earlier. The highs in the table came in Q4 2025, at $4.67 per share and $708.5 million in revenue. Medpace beat the EPS estimate in all 20 quarters shown, with surprises from 0.81% to 39.03%.
Medpace reported Q3 between October 21 and October 25 in each of the past five years. That points to late October 2026 for the next report. It will show whether revenue moves beyond the level of the last three quarters.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 22, 2026 | $3.98 | $4.25 | +6.83% | $707.3M | SEC |
| Q1 2026 | Apr 22, 2026 | $3.92 | $4.28 | +9.17% | $706.6M | SEC |
| Q4 2025 | Feb 9, 2026 | $4.19 | $4.67 | +11.58% | $708.5M | SEC |
| Q3 2025 | Oct 22, 2025 | $3.53 | $3.86 | +9.20% | $659.9M | SEC |
| Q2 2025 | Jul 21, 2025 | $2.98 | $3.10 | +3.94% | $603.3M | SEC |
| Q1 2025 | Apr 21, 2025 | $3.06 | $3.67 | +19.95% | $558.6M | SEC |
| Q4 2024 | Feb 10, 2025 | $2.94 | $3.67 | +24.87% | $536.6M | SEC |
| Q3 2024 | Oct 21, 2024 | $2.77 | $3.01 | +8.64% | $533.3M | SEC |
| Q2 2024 | Jul 22, 2024 | $2.54 | $2.75 | +8.33% | $528.1M | SEC |
| Q1 2024 | Apr 22, 2024 | $2.47 | $3.20 | +29.79% | $511.0M | SEC |
| Q4 2023 | Feb 12, 2024 | $2.22 | $2.46 | +10.78% | $498.4M | SEC |
| Q3 2023 | Oct 23, 2023 | $2.05 | $2.22 | +8.49% | $492.5M | SEC |
| Q2 2023 | Jul 24, 2023 | $1.91 | $1.93 | +0.81% | $460.9M | SEC |
| Q1 2023 | Apr 24, 2023 | $1.82 | $2.27 | +25.06% | $434.1M | SEC |
| Q4 2022 | Feb 13, 2023 | $1.79 | $2.12 | +18.73% | $394.1M | SEC |
| Q3 2022 | Oct 24, 2022 | $1.47 | $2.05 | +39.03% | $383.7M | SEC |
| Q2 2022 | Jul 25, 2022 | $1.31 | $1.46 | +11.28% | $351.2M | SEC |
| Q1 2022 | Apr 25, 2022 | $1.26 | $1.69 | +34.13% | $330.9M | SEC |
| Q4 2021 | Feb 14, 2022 | $1.25 | $1.32 | +5.60% | $308.6M | SEC |
| Q3 2021 | Oct 25, 2021 | $1.08 | $1.29 | +19.44% | $295.6M | SEC |
Quarterly revenue
Frequently asked questions
When did Medpace Holdings (MEDP) last report earnings?
Medpace Holdings last reported on Jul 22, 2026, covering fiscal Q2 2026.
Did MEDP beat earnings estimates?
Yes. Medpace Holdings reported EPS of $4.25 for Q2 2026 against a $3.98 estimate — a 6.83% beat.
How much revenue did MEDP report last quarter?
Medpace Holdings reported $707.3M in revenue for Q2 2026, against a consensus estimate of $689.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.